Journals / MN Kardiyoloji / 2022 / Cilt: 29 - Sayı: 1

The Role of Fibulin-1 and Fibulin-5 Measurement in Identification of Subjects with Pulmonary Arterial Hypertension: Cross-Sectional, Observational Study

Pulmoner Arteryel Hipertansiyonu Olan Olguların Belirlenmesinde Fibulin-1 ve Fibulin-5 Ölçümünün Rolü: Kesitsel Gözlemsel Bir Çalışma

Pages
14–19
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Median fibulin‐1 [4,5 μg/mL (0,4‐22,7) vs, 1,01 (0,3‐9,6), p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectice: Pulmonary arterial hypertension is associated with severe morbidity and mortality.
📊
Key Findings & Data:The aim of this study was to investi‐ gate the association between fibulin‐1 and ‐5 in patients with pulmonary arterial hypertension.
💡
Conclusion & Impact:Results: Median fibulin‐1 [4,5 μg/mL (0,4‐22,7) vs, 1,01 (0,3‐9,6), p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectice: Pulmonary arterial hypertension is associated with severe morbidity and mortality. Findings of transthoracic echocardiogra‐ phy, thorax computed tomography and cardiac catheterization may give clues regarding the mortality associated with pulmonary ar‐ terial hypertension. However, there is still need for simple blood test that could provide information concerning the severity of pul‐ monary arterial hypertension, fibulin proteins have been shown to have diagnostic and predictive role in several cardiovascular disor‐ ders. However, data is lacking concerning the role of fibulins in pulmonary arterial hypertension. The aim of this study was to investi‐ gate the association between fibulin‐1 and ‐5 in patients with pulmonary arterial hypertension. Material and Method: 26 group 1 pulmonary arterial hypertension patients and 30 healthy controls were included in this cross‐sec‐ tional, observational study. The serum fibulin‐1 and ‐5 levels were measured in all subjects using ELISA, diagnosis of pulmonary arterial hypertension was based on echocardiography and cardiac catheterization. Subjects with pulmonary arterial hypertension also under‐ went 6‐minutes walking test. The difference in blood levels of fibulin‐1 and ‐5 between subjects with pulmonary arterial hypertension and healthy controls was the primary outcome measure of this study. Results: Median fibulin‐1 [4,5 μg/mL (0,4‐22,7) vs, 1,01 (0,3‐9,6), p

Özet

Amac: Pulmoner arteryel hipertansiyon ciddi morbidite ve mortalite oranları ile ilişkilidir. Transtorasik ekokardiyografi, toraks bilgisa‐ yarlı tomografisi ve kardiyak kateterizasyon bulguları pulmoner arteryel hipertansiyon ile ilişkili mortalite sonuçları hakkında ipuçları ve‐ rebilir. Bununla birlikte, yine de pulmoner arteryel hipertansiyonun şiddeti hakkında bilgi sağlayabilecek basit bir kan testine hala ihti‐ yaç bulunmaktadır. Çeşitli kardiyovasküler bozukluklarda fibulin proteinlerinin tanısal ve öngörücü rolü olduğu gösterilmiştir. Ancak fi‐ bulinlerin pulmoner arteriyel hipertansiyondaki rolüne ilişkin veriler eksiktir. Bu çalışmanın amacı, pulmoner arteryel hipertansiyonlu hastalarda fibulin‐1 ve fibulin‐5 arasındaki ilişkinin araştırılmasıdır. Gereç ve Yöntem: Bu kesitsel, gözlemsel çalışmaya 26 Grup‐1 pulmoner arteryel hipertansiyon hastası ve 30 sağlıklı kontrol dahil edil‐ miştir. Serum fibulin‐1 ve fibulin‐5 seviyeleri tüm deneklerde ELISA kullanılarak ölçülmüştür. Pulmoner arteryel hipertansiyon tanısı eko‐ kardiyografi ve kalp kateterizasyonuna dayanmaktadır. Pulmoner arteryel hipertansiyonlu deneklere ayrıca 6 dakikalık yürüme testi uy‐ gulanmıştır. Bu çalışmanın birincil sonuç ölçütü; pulmoner arteryel hipertansiyonlu denekler ve sağlıklı kontroller arasındaki fibulin‐1 ve fibulin‐5 kan seviyelerinde fark olmuştur. Bulgular: Medyan fibulin‐1 [4,5 μg/mL (0,4‐22,7) vs, 1,01 (0,3‐9,6), p

🔖

Cite This Article

GÜNGÖR, H., GÜLAŞTI, S., AKGÜLLÜ, Ç., ZENCİR, C., YILMAZ, M., ERYILMAZ, U. (2022). The Role of Fibulin-1 and Fibulin-5 Measurement in Identification of Subjects with Pulmonary Arterial Hypertension: Cross-Sectional, Observational Study. MN Kardiyoloji, Cilt: 29 - Sayı: 1, 14–19. https://ajindex.com/articles/581439

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Yurdakul S. Aytekin S. Pulmoner hipertansiyonda tanı algoritmaları. Anadolu Kardiyol Derg. 2010;10 (Özel Sayı 1):1426
  2. Kherbeck N. Tamby MC. Bussone G. et al. The role of in flammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension. Clin Rev Allergy Immunol. 2013;44(1):318
  3. Öztürk Ö. Akkaya A. Pulmoner arteriyel hipertansiyon: patogenez. SDÜ Tıp Fak Derg. 2008;15(4):4653
  4. Maron BA. Galiè N. Pulmonary arterial hypertension diag nosis, treatment, and clinical management in the contem porary era. JAMA Cardiol. 2016;1(9):1056
  5. Barış SA. Yıldız F. Pulmoner Hipertansiyon Tanımı, Ağırlığı ve Prognostik Faktörlerin Değerlendirilmesi. T Klin J Cardiovasc Sci. 2012;24(3):2605
  6. Timpl R. Sasaki T. Kostka G. Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 2003;4(6):47989
  7. Roark EF. Keene DR. Haudenschild CC. Godyna S. Little CD. Argraves WS. The association of human fibulin1 with elas tic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem. 1995;43(4):40111
  8. Chapman SL. Sicot FX. Davis EC. et al. Fibulin2 and fibulin 5 cooperatively function to form the internal elastic lamina and protect from vascular injury. Arterioscler Thromb Vasc Biol. 2010;30(1):6874
  9. Brandsma CA. van den Berge M. Postma DS. et al. A large lung gene expression study identifying fibulin5 as a novel player in tissue repair in COPD. Thorax. 2015;70(1):2132
  10. Hu L. Dong MX. Zhao H. Xu GH. Qin XY. Fibulin5: a novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage. Eur J Neurol. 2016;23(7):1195201
  11. Yan B. Hu Y. Ma T. Wang Y. IDH1 mutation promotes lung cancer cell proliferation through methylation of Fibulin5. Open Biol. 2018;8(10):180086
  12. Sztrymf B. Souza R. Bertoletti L. et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hy pertension. Eur Respir J. 2010;35(6):128693
  13. Farber HW. Loscalzo J. Pulmonary arterial hypertension. New Engl J Med. 2004;351(16):165565
  14. Humbert M. Morrell NW. Archer SL. et al. Cellular and molecular pathobiology of pulmonary arterial hyperten sion. J Am Coll Cardiol. 2004;43(12 Supplement):S1324
  15. Reinhardt DP. Sasaki T. Dzamba BJ. et al. Fibrillin1 and fibulin2 interact and are colocalized in some tissues. J Biol Chem. 1996;271(32):1948996
  16. Kostka G. Giltay R. Bloch W. et al. Perinatal lethality and endothelial cell abnormalities